User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs).

Primary tabs

Henriet, Patrick [UCL] Cornet, Patricia B [UCL] Lemoine, Pascale [UCL] Galant, Christine [UCL] Singer, Christian F [UCL] Courtoy, Pierre J. [UCL] Eeckhout, Yves [UCL] Marbaix, Etienne [UCL]

Recent studies strongly suggest that matrix metalloproteinases (MMPs) play a key role in the initiation of menstrual bleeding in the human endometrium upon the fall of ovarian steroid serum concentrations by inducing the degradation of the extracellular matrix of this mucosa. MMPs are also involved in abnormal endometrial bleeding and have been identified in endometriotic foci. In all cases, they are associated with areas of extracellular matrix breakdown. This paper reviews the literature on the regulation by estradiol and progesterone of the expression and activation of MMPs, and of the expression of their tissue inhibitors (TIMPs), (i) in the endometrium in situ during normal cycle, (ii) during artificial cycles in spayed monkeys, and (iii) in cultures of endometrial explants or purified cells. Whereas progesterone consistently decreases the activity of endometrial MMPs, its effects vary in intensity, duration, and pattern between MMPs as well as among experimental systems. The contribution and limitations of the various investigations are therefore discussed. The focal heterogeneity points to additional local controls of the expression and activation of MMPs in human endometrium, acting beyond the general inhibitory role of progesterone, for example, by cytokines. Focal changes in type or abundance of sex steroid receptors also could be responsible for spatial variation in the expression of MMPs in the endometrium and endometriotic lesions.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2002
Journal information "Annals of the New York Academy of Sciences" - Vol. 955, p. 119-38; discussion 157-8, 396-406 (2002)
Peer reviewed yes
issn 0077-8923
Publication status Publié
Affiliations UCL - MD/BICL - Département de biochimie et de biologie cellulaire
UCL - MD/MNOP - Département de morphologie normale et pathologique
MESH Subject Animals ; Cytokines - physiology ; Endometrium - enzymology - physiology ; Enzyme Activation ; Estradiol - blood - physiology ; Female ; Humans ; Matrix Metalloproteinases - metabolism ; Ovary - metabolism ; Progesterone - blood - physiology ; Receptors, Progesterone - physiology ; Tissue Inhibitor of Metalloproteinases - metabolism
Keywords Endometrium ; Estradiol ; Progesterone ; Matrix metallopoteinases ; Tissue inhibitors
Links
  1. Hulboy, Mol. Hum. Reprod., 3, 27 (1997)
  2. 2Eeckhout, Y. & P. Henriet. 2002. Matrix metalloproteinases. In The Encyclopedia of Molecular Medicine. Wiley. New York. In press.
  3. Manes, J. Biol. Chem., 272, 25706 (1997)
  4. Park, J. Biol. Chem., 275, 20540 (2000)
  5. 5Henriet, P. & Y. Eeckhout. 2002. Tissue inhibitors of matrix metalloproteinases. In The Encyclopedia of Molecular Medicine. Wiley. New York. In press.
  6. Will, J. Biol. Chem., 271, 17119 (1996)
  7. Hampton, J. Endocrinol., 141, R1 (1994)
  8. Marbaix E, Kokorine I, Henriet P, Donnez J, Courtoy P J, Eeckhout Y, The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation, 10.1042/bj3051027
  9. Marbaix E., Kokorine I., Donnez J., Eeckhout Y., Courtoy P. J., Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruation, 10.1093/humrep/11.suppl_2.134
  10. Irwin, J. Clin. Invest., 97, 438 (1996)
  11. Higuchi, Endocrinology, 136, 4973 (1995)
  12. Rodgers, J. Clin. Invest., 94, 946 (1994)
  13. 13Freitas, S., G. Meduri et al. 1999. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol. Reprod. 61: 1070-1082.
  14. Kokorine, J. Cell Sci., 109, 2151 (1996)
  15. Rodgers William H., steen Kevin G., Matrisian Lynn M., Navre Marc, Giudice Linda C., Gorstein Fred, Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle, 10.1016/s0002-9378(12)90922-9
  16. Koks, Fertil. Steril., 73, 604 (2000)
  17. Maatta, Am. J. Clin. Pathol., 114, 402 (2000)
  18. Rigot, Biochem. J., 358, 275 (2001)
  19. Skinner, Hum. Reprod., 14, 793 (1999)
  20. Jeziorska, J. Reprod. Fertil., 107, 43 (1996)
  21. Soini, Hum. Pathol., 28, 220 (1997)
  22. Zhang, Biol. Reprod., 62, 85 (2000)
  23. Zhang, Mol. Hum. Reprod., 3, 735 (1997)
  24. 24Marbaix, E., I. Kokorine, P. Moulin et al. 1996. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc. Natl. Acad. Sci. U.S.A. 93: 9120-9125.
  25. Rudolph-Owen, Biol. Reprod., 59, 1349 (1998)
  26. Cornillie, Contraception, 43, 387 (1991)
  27. Marbaix, Proc. Natl. Acad. Sci. U.S.A., 89, 11789 (1992)
  28. Osteen, Proc. Natl. Acad. Sci. U.S.A., 91, 10129 (1994)
  29. Bruner, Steroids, 64, 648 (1999)
  30. Rawdanowicz, J. Clin. Endocrinol. Metab., 79, 530 (1994)
  31. Schatz, Ann. N.Y. Acad. Sci., 732, 479 (1994)
  32. Schatz, J. Clin. Endocrinol. Metab., 78, 1467 (1994)
  33. Singer, Eur. J. Biochem., 259, 40 (1999)
  34. Lockwood, Endocrinology, 139, 4607 (1998)
  35. Hampton, Mol. Hum. Reprod., 5, 365 (1999)
  36. Schatz, J. Clin. Endocrinol. Metab., 82, 188 (1997)
  37. Salamonsen, J. Clin. Endocrinol. Metab., 82, 1409 (1997)
  38. Bryant-Greenwood, Mol. Cell. Endocrinol., 95, 23 (1993)
  39. Singer, Proc. Natl. Acad. Sci. U.S.A., 94, 10341 (1997)
  40. Tseng, Obstet. Gynecol. Annu., 8, 1 (1979)
  41. Aronica, Endocrinology, 128, 2045 (1991)
  42. Tamaya, Acta Obstet. Gynecol. Scand., 65, 195 (1986)
  43. Sartorius, Mol. Endocrinol., 8, 1347 (1994)
  44. Giangrande, J. Biol. Chem., 272, 32889 (1997)
  45. Hovland, J. Biol. Chem., 273, 5455 (1998)
  46. Conneely, Steroids, 65, 571 (2000)
  47. Beato, FASEB J., 5, 2044 (1991)
  48. Uht, Endocrinology, 138, 2900 (1997)
  49. Bamberger, Proc. Natl. Acad. Sci. U.S.A., 93, 6169 (1996)
  50. Chauchereau, J. Biol. Chem., 275, 8540 (2000)
  51. Keller, J. Clin. Endocrinol. Metab., 85, 1611 (2000)
  52. Osteen, Ann. N.Y. Acad. Sci., 828, 137 (1997)
  53. Osteen, Gynecol. Obstet. Invest., 48, 2 (1999)
  54. Bruner, Proc. Natl. Acad. Sci. U.S.A., 92, 7362 (1995)
  55. Galant, J. Clin. Endocrinol. Metab., 85, 4827 (2000)
  56. Marbaix E., Vekemans M., Galant C., Rigot V., Lemoine P., Dubois D., Picquet C., Henriet P., Twagirayezu P., Sufi S., Eeckhout Y., Courtoy P.J., Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users, 10.1093/humrep/15.suppl_3.120
  57. Brosens, Am. J. Obstet. Gynecol., 176, 263 (1997)
  58. Kokorine, Fertil. Steril., 68, 246 (1997)
Bibliographic reference Henriet, Patrick ; Cornet, Patricia B ; Lemoine, Pascale ; Galant, Christine ; Singer, Christian F ; et. al. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs).. In: Annals of the New York Academy of Sciences, Vol. 955, p. 119-38; discussion 157-8, 396-406 (2002)
Permanent URL http://hdl.handle.net/2078.1/9133